References
- Ho A., Seither E., Ma D., Prentice H. Mitoxantrone-induced toxicity and DNA strand breaks in leukaemic cells. Br. J. Haematol. 1987; 65: 51–55
- Alberts D., Peng Y., Bowden G., Mackel C., Dalton W. Mechanism of action and pharmacokinetics of Novantrone in intravenous and intraperitoneal therapy. Proceedings of the symposium on the current status of Novantrone. 1985; 21–24, 15-21
- Ehninger G., Schuler U., Proksch B., Zeller K., Blanz J. Pharmacokinetics and metabolism of mitoxantrone, a review. Clin. Pharmacokinet. 1990; 18: 365–380
- Savaraj N., Lu K., Manuel V., Loo T. Pharmacology of mitoxantrone in cancer patients. Cancer Chemother. Pharmacol 1982; 8: 113–117
- Stewart D., Green R., Mikhael N., Montpetit V., Thibault M., Maroun J. Human autopsy tissue concentrations of mitoxantrone. Cancer Treat. Rep. 1986; 70: 1255–1261
- Bjorkholm M., Bjornsdottir J., Stenke L., Grimfors G. Mitoxantrone, etoposide and cytarabine in the treatment of acute nonlymphocytic leukemia. Oncology 1990; 47: 112–114
- Larson R., Daly K., Choi K., Han D., Sinkule J. A clinical and pharmacokinetic study of mitoxantrone in acute nonlymphocytic leukemia. J. Clin. Oncol 1987; 5: 391–397
- Dunne A. JANA: A new iterative polyexponential curve stripping program. Comput. Methods Programs Biomed. 1985; 20: 269–275
- Eksborg S., Strandler H., Edsmyr F., Naslund I., Tahvanainen P. Pharmacokinetic study of iv infusions of adriamycin. Eur. J. Clin. Pharmacol. 1985; 28: 205–212
- Tidefelt U., Sundman-Engberg B., Paul C. Comparison of the intracellular pharmacokinetics of doxorubicin and 4′-epi-doxorubicin in patients with acute leukemia. Cancer Chemother. Pharmacol 1989; 24: 225–229
- Paul C., Liliemark J., Tidefelt U., Gahrton G., Peterson C. Pharmacokinetics of daunorubicin and doxorubicin in plasma and leukemic cells from patients with acute nonlymphoblastic leukemia. Ther. Drug Monit. 1989; 11: 140–148
- Faulds D., Balfour J., Chrisp P., Langtry H. Mitoxantrone—A review of its pharmacodynamic properties, and therapeutic potential in the chemotherapy of cancer. Drugs 1991; 41: 400–449
- Kaminer L., Choi K., Daley K., Larson R. Continuous infusion of mitoxantrone in relapsed acute nonlymphocytic leukemia. Cancer 1989; 65: 2619–2623
- Deuchars K., Ling V. P-glycoprotein and multidrug resistance in cancer chemotherapy. Semin. Oncol. 1989; 16: 156–165
- Plunkett W., Iacoboni S., Estey E., Danhauser L., Liliemark J., Keating M. Pharmacologically directed ara-C therapy for refractory leukemia. Semin. Oncol. 1985; 12(suppl. 3)20–30